Skincare Ingredient Science and Derm Studies — 2026-10-23
The first new FDA-approved sunscreen filter in over 25 years, bemotrizinol, has officially hit US store shelves, marking a significant shift in photoprotection efficacy. Meanwhile, a new systematic review highlights the growing evidence for oral and topical peptides in combating skin aging, while Korean manufacturers showcase advanced UV and AI-driven hair loss technologies at international congresses.
Skincare Ingredient Science and Derm Studies — 2026-10-23
Top developments
Bemotrizinol Delivers First New UV Filter to US Shelves in Decades
For the first time in 27 years, Americans have access to a new sunscreen active ingredient. Bemotrizinol (BEMT), which received FDA approval in June 2026 and became effective in August, is now available in commercial products. This filter, long used in Europe and Asia, offers broad-spectrum protection against UV A and B rays without the white residue associated with older mineral filters.
Systematic Review Validates Peptides for Skin Aging
A recent systematic review and meta-analysis published in Frontiers in Medicine confirms the efficacy of both oral and topical peptides in reducing signs of skin aging. The analysis of randomized controlled trials demonstrates that peptide-based therapies significantly enhance collagen production and improve skin elasticity and roughness, providing stronger scientific backing for these popular cosmeceutical ingredients.
Korean Cosmetics Giant Showcases AI and UV Tech
At the World Congress of the International Federation of Societies of Cosmetic Chemists, Cosmax presented diverse research achievements, including advanced UV blocking technologies and an AI-based hair loss prediction model. These developments highlight the increasing integration of artificial intelligence in dermatological diagnostics and formulation science within the K-beauty sector.
Local view
Japan: Functional Foods and Retinol Alternatives Gain Traction
In Japan, the market for functional foods aimed at skin protection is projected to reach $2.64 billion by 2030, reflecting a consumer shift toward internal skincare solutions. Additionally, Japanese dermatologists and clinics are increasingly presenting research on retinol alternatives and advanced skin boosters at local aesthetic medicine conferences, emphasizing tolerance alongside efficacy.
Korea: Focus on New Bio-Ingredients and Congress Innovation
Korean media highlights the upcoming In-Cosmetics Asia event in Bangkok, where over 120 innovative ingredients will be showcased. Key areas of interest include AI-driven ingredient discovery and new UV blocking formulations, positioning Korean suppliers as leaders in next-generation raw material development.
Context & numbers
FDA Regulatory Timeline: The FDA added bemotrizinol to the OTC sunscreen monograph in June 2026, with the final order becoming effective on August 9, 2026. This action ended a 27-year freeze on new OTC sunscreen ingredients in the United States.
Market Access: DSM-Firmenich holds exclusive marketing rights for bemotrizinol for the first 18 months following its US launch, potentially influencing initial pricing and availability.
On the radar
- In-Cosmetics Asia (Nov 3–5, 2026): Scheduled for Bangkok, this event will feature significant presentations on AI in ingredient development and novel UV filters.
- Bemotrizinol Adoption: Watch for further launches from major brands beyond Neutrogena and Aveeno, as the 18-month exclusivity period for DSM-Firmenich continues.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
